ライフサイエンスコーパス: peritoneal fluid

1 e appearance of TNF or IL-6 in the plasma or peritoneal fluid.

2 and ectopic endometrium, and on monocytes in peritoneal fluid.

3 ted arachidonic acid (AA) derivatives in the peritoneal fluid.

4 Two resident macrophage subsets reside in peritoneal fluid.

5 as cerebrospinal fluid, synovial fluid, and peritoneal fluid.

6 s, neutrophil influx, and a pH of 7.9 within peritoneal fluid.

7 asate, but have limited ability to reach the peritoneal fluid.

8 model based on mastocytes isolated from rat peritoneal fluid.

9 A or B) tumors and in cytologically negative peritoneal fluid.

10 ignificantly (P < 0.05) increased tPA in the peritoneal fluid.

11 me-dependent increase in IL-10 in plasma and peritoneal fluid.

12 in biologically active TNF in the plasma and peritoneal fluid.

13 IFNgamma (p = .001) levels were found in the peritoneal fluid.

14 thickening (51.2% vs 13.3%, P = .0167), free peritoneal fluid (82.8% vs 33.3%, P = .002), extent of P

15 rget microscopic spheroids persisting in the peritoneal fluid after debulking surgery.

16 e number of viable bacteria in the blood and peritoneal fluid and accelerated killing of bacteria by

17 ive the stresses of anchorage-free growth in peritoneal fluid and ascites, and to colonize remote sit

18 uclease (RNase) A Superfamily are present in peritoneal fluid and increase during peritonitis in pati

19 red numbers of myeloid and T cell subsets in peritoneal fluid and increased giant cells within the le

20 amount of parasite in the brain, spleen, and peritoneal fluid and reducing brain cysts by >85%.

21 Dose-dependent CEA elevation in peritoneal fluid and serum was observed.

22 Among several cytokines surveyed in peritoneal fluid and serum, IL-6 is highly and different

23 ells and spheroids detach, float through the peritoneal fluid and take over new sites, with spheroids

24 dissemination of chemoresistant cells in the peritoneal fluid and the immunosuppressive microenvironm

25 orm to enrich ATCs from highly heterogeneous peritoneal fluid and then perform molecular analyses on

26 Peritoneal fluid and tissue were collected at day 1 to m

27 fallopian tube), Peritoneal (viable cells in peritoneal fluid), and Metastatic (cells implanted on ot

28 increased levels of IL-10 in both serum and peritoneal fluid, and increased expression of the IL-10

29 rs, intestinal wet/dry ratios, urine output, peritoneal fluid, and intraluminal fluid were measured.

30 throughout the peritoneum, initially via the peritoneal fluid, and later via ascites that accumulates

31 icited chemokine production in the serum and peritoneal fluid as well as the recruitment of neutrophi

32 antly reduced in splenic homogenates but not peritoneal fluid at 24 hrs.

33 SARS-CoV-2 was detected in peritoneal fluid at a higher concentration than in respi

34 From these patients, we collected cells from peritoneal fluid, blood, lymph, and biopsies.

35 om numerous body sites, including the blood, peritoneal fluid, bone, synovial fluid, a perianal absce

36 The chemokine KC was reduced in the peritoneal fluid but not the plasma and endogenous IL-10

37 n urine, cerebrospinal fluid, and pleural or peritoneal fluid, but also consider other sources of ctD

38 VEGF-A was measured in peritoneal fluid by ELISA (n = 16).

39 PDGF AA and BB were quantified in peritoneal fluid by ELISA.

40 Carried by the peritoneal fluid, cancer cell spheroids overcome anoikis

41 elevated of levels of TNF-alpha and CXCL1 in peritoneal fluid compared with wild-type mice.

42 Peritoneal fluid concentrations of prostaglandin E2 (PGE

43 cal adhesion bands were graded on day 7, and peritoneal fluid concentrations of tissue plasminogen ac

44 Furthermore, the liposome-containing peritoneal fluid contained significantly higher ammonia

45 to lysis of intraperitoneal PMN, because the peritoneal fluids contained free myeloperoxidase and ind

46 hus, the secretion of such vesicles into the peritoneal fluid could be a determinant factor in the di

47 observational study to assess the impact of peritoneal fluid-derived sEVs (PFD-sEVs) in OvCa clinica

48 The total burden of TP53 mutations in peritoneal fluid distinguished cancers from controls wit

49 Hypermethylation was detected in 28 of 30 peritoneal fluid DNA from stage IC-IV patients, includin

50 There was a significantly lower peritoneal fluid drainage from the ABThera at 48 hours a

51 not seem to be mediated by an improvement in peritoneal fluid drainage, fascial closure rates, or mar

52 sult describing the presence of the virus in peritoneal fluid during an emergency surgical procedure

53 hat resident macrophages were nonadherent in peritoneal fluid during homeostasis.

54 he Nlrp3(+/+) neutrophils collected from the peritoneal fluid formed significantly more filaments (sp

55 these findings using targeted proteomics of peritoneal fluid from endometriosis patients and find gr

56 Postoperative peritoneal fluid from infected patients enhanced both ce

57 els in peritoneal tissue and tPA activity in peritoneal fluid from lovastatin-treated animals were in

58 tations (median mutant fraction 1/13,139) in peritoneal fluid from nearly all patients with and witho

59 Interestingly, peritoneal fluid from neonatal mice contained significan

60 wild-type mice and were markedly reduced in peritoneal fluid from septic myeloperoxidase-deficient m

61 els of 3-bromotyrosine also were elevated in peritoneal fluid from septic wild-type mice and were mar

62 We obtained peritoneal fluid from six women with early stage endomet

63 analogue enhancement to study the effect of peritoneal fluid from women with early stage endometrios

64 VEGF-A was increased in peritoneal fluid from women with endometriosis and level

65 Concentrations of IGF-1 were elevated in peritoneal fluid from women with endometriosis and posit

66 significantly lower in the incubations with peritoneal fluid from women with endometriosis than cont

67 factor-beta1 (TGF-beta1) is elevated in the peritoneal fluid from women with endometriosis, and expo

68 etect extremely rare cancer cells present in peritoneal fluid from women with high-grade serous ovari

69 hin peritoneal fluids from these mice, while peritoneal fluids from CLP mice that received preimmune

70 Peritoneal fluids from L-NAME-treated mice contained sig

71 ngly, Gram staining revealed bacteria within peritoneal fluids from these mice, while peritoneal flui

72 ctivity in the presence of mouse serum or in peritoneal fluid, further evidence for its indirect anti

73 Detection of SARS-CoV-2 in peritoneal fluid has never been reported.

74 Proteomic analysis of the peritoneal fluid identified infection-related proteins,

75 Lower plasma and peritoneal fluid IL-6 concentrations in the IL-6 -174 C-

76 derived from standard clinical collection of peritoneal fluid in patients undergoing surgery for PA.

77 uggest that the presence of bacterial DNA in peritoneal fluid in patients with cirrhosis and ascites

78 aired cancer cell clustering in vitro and in peritoneal fluid in vivo, while CM containing only Y318A

79 undant in both endometriotic lesions and the peritoneal fluid in women with endometriosis.

80 Oral DCA reduced peritoneal fluid lactate concentrations and endometriosi

81 Although plasma and peritoneal fluid levels of IL-33 have been associated wi

82 At 20 hours after CLP, plasma and peritoneal fluid levels of TNF-alpha and IL-6 were deter

83 These macrophages were derived from peritoneal fluid macrophages and exhibited a unique gene

84 x that was isolated from the pericardial and peritoneal fluid of a 13-year-old female liver transplan

85 type strain NRRL Y-27500, CBS 2985, from the peritoneal fluid of a dead guinea pig), and K. slooffiae

86 tly fewer total aerobes and anaerobes in the peritoneal fluid of animals challenged with cecal conten

87 supernatants and viable cells obtained from peritoneal fluid of chronic PD patients.

88 BDNF concentrations trended higher in peritoneal fluid of endometriosis cases but were not sta

89 tracellular vesicles (EVs) isolated from the peritoneal fluid of endometriosis patients and controls.

90 are elevated in the systemic circulation and peritoneal fluid of endometriosis patients; however, whe

91 ovo secretion of YB-1 into the urine and the peritoneal fluid of LPS-treated mice.

92 INH bound to bacteria cultured from blood or peritoneal fluid of mice with CLP-induced sepsis, but ha

93 that its concentrations are elevated in the peritoneal fluid of patients compared with control subje

94 RET substrates, we applied the method to the peritoneal fluid of subjects with and without the invasi

95 Subsequently, we isolated small EVs from the peritoneal fluid of women diagnosed with endometriosis a

96 A, an angiogenic factor, is increased in the peritoneal fluid of women with endometriosis.

97 recurvatus was isolated from the pleural and peritoneal fluids of a 64-year-old man with a history of

98 ly phagocytosed by macrophages prepared from peritoneal fluids of thioglycolate-treated mice.

99 frequency between fallopian tubes exposed to peritoneal fluids of women with and without endometriosi

100 Amylase, a promising biomarker present in peritoneal fluid, offers hope for early and long-term de

101 Disseminated cancer cells in the peritoneal fluid often colonize omental fat-associated l

102 the tumor dose without affecting the dose to peritoneal fluid or bone marrow.

103 no considerable increase was found in either peritoneal fluid or serum after CLP.

104 lation was observed in nonneoplastic tissue, peritoneal fluid, or serum from 40 control women (100% s

105 rebound (P < 0.001), and CT scan findings of peritoneal fluid (P = 0.01), fecalith (P = 0.01), dilati

106 the areas of the physiological stasis of the peritoneal fluid: pelvic peritoneal reflections, right a

107 At 4 h post-LPS, peritoneal fluid (PF) and white blood cells (WBC) were c

108 Peritoneal fluid (PF) was obtained by intraoperative lav

109 Chemokines and cytokines in the peritoneal fluid (PF) were quantified using ELISA.

110 ased cytokine and chemokine secretion in the peritoneal fluid (PF), as well as MO infiltration, vascu

111 acteremia and bacterial growth in samples of peritoneal fluid (PF), liver, spleen, kidneys, heart, an

112 Large peritoneal fluid pockets are moderately predictive of ma

113 Analyze peritoneal fluid resistance patterns in patients with a

114 plasma, serum, milk, urine, amniotic fluid, peritoneal fluid, saliva, follicular fluid, and fluid fr

115 Here, we report the analysis of peritoneal fluid samples from 258 patients with malignan

116 lture techniques for diagnosis of SBP in 106 peritoneal fluid samples from patients with suspected SB

117 TP53 mutation was detected in 94% (16/17) of peritoneal fluid samples from women with HGSOC (frequenc

118 x sequencing to analyze TP53 mutations in 17 peritoneal fluid samples from women with HGSOC and 20 fr

119 d using baseline and postoperative serum and peritoneal fluid samples to determine cell proliferation

120 Culture of the peritoneal fluid showed gram-negative organisms.

121 e, even in complex samples such as simulated peritoneal fluid (SPF).

122 utrophil infiltration and greater burdens in peritoneal fluid than SC5314 did and abscesses that pers

123 idneys, testis and epididymis with echogenic peritoneal fluid tracking into both scrotal sacs.

124 t decreased bacterial loads in the blood and peritoneal fluid, ultimately improving their survival.

125 the PDGFR in ovarian tumors, cell lines and peritoneal fluid using RT-PCR, immunohistochemistry (IHC

126 Fibrinolytic activity in peritoneal fluid was assayed by zymography, and expressi

127 Bacterial load in peritoneal fluid was reduced in CpG ODN-treated versus n

128 hed tumor, preoperative serum or plasma, and peritoneal fluid (washes or ascites) DNA obtained from 5

129 On study days 1, 2, 3, 7, and 28, blood and peritoneal fluid were collected.

130 Blood, stool, and liver biopsies and peritoneal fluid were cultured (circa 4000 total specime